Related Experiment Video
Updated: May 5, 2026

Affinity Purification of Influenza Virus Ribonucleoprotein Complexes from the Chromatin of Infected Cells
Published on: June 3, 2012
Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target
Sylvie Chenavas1, Thibaut Crépin, Bernard Delmas
1Université Grenoble Alpes, Unit of Virus Host Cell Interactions, F-38000 Grenoble, France.
Abstract:
The nucleoprotein (NP) of influenza virus covers the viral RNA entirely and it is this NP-RNA complex that is the template for transcription and replication by the viral polymerase. Purified NP forms a dynamic equilibrium between monomers and small oligomers, but only the monomers can oligomerize onto RNA. Therefore, drugs that stabilize the monomers or that induce abnormal oligomerization may have an antiviral effect, as would drugs that interfere with RNA binding. Crystal structures have been produced for monomeric and dimeric mutants, and for trimers and tetramers; high-resolution electron microscopy structures have also been calculated for the viral NP-RNA complex. We explain how these structures and the dynamic oligomerization equilibrium of NP can be and have been used for anti-influenza drug development.
Related Concept Videos
Influenza
Inhibitors of Viral Protein Synthesis
Leaky Scanning
Viruses with RNA Genomes
Viral Structure
Size and Structure of Viral Genomes

